In a healthy young patient under general anaesthesia, continuous three‑lead ECG monitoring shows 3 mm ST elevation in leads II and III but not lead I; what is the likely cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ST Elevation in Leads II and III During General Anesthesia: Most Likely Non-Cardiac Causes

In a healthy young patient under general anesthesia showing 3mm ST elevation in leads II and III but NOT in lead I, the most likely causes are technical artifacts (lead misplacement, electrode issues) or benign physiologic variants rather than true myocardial ischemia.

Algorithmic Approach to This ECG Finding

Step 1: Rule Out Technical Issues FIRST

  • Check for limb lead reversal or misplacement - This is the most common cause of paradoxical ST patterns during monitoring 1
  • Verify electrode placement and connections
  • Look for unusual P-QRS patterns that suggest lead reversal 1
  • Repeat the ECG immediately - if findings normalize, this strongly suggests artifact 2

Step 2: Assess the Clinical Context

The absence of ST elevation in lead I is the critical distinguishing feature here:

True inferior MI pattern (RCA or LCx occlusion) would show:

  • ST elevation in leads II, III, AND aVF together 3
  • When RCA is occluded: ST elevation greater in lead III than lead II, often WITH ST depression in leads I and aVL 3
  • The pattern you describe (II and III elevated, but NOT lead I) is atypical for true ischemia

Step 3: Consider Benign Mimickers in Young Healthy Patients

Atrial repolarization (Ta wave):

  • Can cause ST elevation that mimics STEMI, especially with low atrial ectopic rhythms 2
  • Resolves spontaneously on repeat ECG 2
  • More likely in young patients without cardiac disease

Early repolarization variant:

  • Common benign finding in young patients 4
  • Can be accentuated during anesthesia
  • Typically shows J-point elevation with upward concavity

Constant ST elevation pattern:

  • Described in obese middle-aged men with hypertension
  • Usually NOT associated with coronary stenosis (only 6.25% had significant disease) 5
  • Associated with LV hypertrophy

Critical Pitfalls to Avoid

  1. Do NOT activate the cath lab based on 3-lead monitoring alone in a hemodynamically stable patient

  2. Do NOT assume ischemia without:

    • Obtaining a full 12-lead ECG immediately
    • Checking troponins (though these lag behind ECG changes)
    • Assessing hemodynamics and clinical context
  3. Recognize that general anesthesia masks symptoms - you cannot rely on chest pain to guide diagnosis 4, 6

Immediate Management Steps

  1. Obtain a full 12-lead ECG immediately - this is diagnostic
  2. Check for hemodynamic instability (hypotension, new wall motion abnormalities on TEE if available)
  3. Verify all monitoring leads are correctly placed
  4. If 12-lead confirms inferior ST elevation in contiguous leads (II, III, aVF) with reciprocal changes, consider true ischemia
  5. If 12-lead shows normalization or different pattern, the 3-lead finding was artifact or benign variant

Why This is Likely NOT Acute MI

  • Healthy young patient = extremely low pretest probability
  • Only 2 leads involved (II and III) without aVF = does not meet criteria for contiguous lead involvement 3
  • Lead I not involved = atypical vector for true inferior ischemia 3
  • Under anesthesia = multiple technical and physiologic confounders 6

The threshold for diagnosing STEMI requires ST elevation ≥0.1 mV in at least 2 anatomically contiguous leads 3. While leads II and III are contiguous, the absence of involvement in lead aVF (the third inferior lead) and the unusual sparing of lead I make this pattern highly suspicious for artifact rather than true ischemia 3.

Related Questions

How should I manage a patient with an asymptomatic ECG showing sinus rhythm and ST‑segment elevation in leads II, III, aVF, I, aVL, V5, and V6?
What is the significance and recommended management of early repolarization observed in the inferior leads of an asthmatic patient?
I had an initial ECG showing an acute ST‑segment elevation myocardial infarction (STEMI), but my provider said it was likely stress‑related and the repeat 12‑lead ECG was normal with low‑decreasing troponin levels; does this mean I had a heart attack and what management is needed?
Is a 2 mm T-wave inversion indicative of myocardial ischemia?
Can improper ECG lead placement cause P‑wave inversion and approximately 1 mm ST‑segment elevation that mimics pericarditis?
How should treatment be managed for a patient with a glucose level of 170 mg/dL who is currently taking metformin 500 mg and gliclazide 40 mg?
What is the recommended oxygen target and initial management for an adult with an acute COPD exacerbation, particularly in patients with a history of hypercapnic respiratory failure or chronic carbon dioxide retention?
What should the 8 am and 8 pm neutral protamine Hagedorn (NPH) insulin doses be, and how should the insulin‑to‑carbohydrate ratio and insulin‑sensitivity factor be adjusted for a 47‑year‑old male with type 2 diabetes, weight 120 kg, normal renal function, relapsed diffuse large B‑cell lymphoma post‑CAR‑T therapy receiving multiple dexamethasone (Decadron) doses, currently on NPH 30 U at 8 am and 25 U at 8 pm with a ratio of 1 U per 6 g carbohydrate and an insulin‑sensitivity factor of 1 U per 20 mg/dL and recent blood glucose values of 245‑317 mg/dL?
What is the recommended intravenous immunoglobulin (IVIG) dosing regimen for an adult with immune thrombocytopenia (ITP)?
For a patient with Behçet’s disease, recurrent oral and genital ulcers, on warfarin with INR 2.3 who develops a new deep vein thrombosis, should we start oral corticosteroids, increase the INR target, switch to enoxaparin (low‑molecular‑weight heparin), or place an inferior vena cava filter?
In a patient receiving chemotherapy who shows an apparent increase in tumor size or new symptoms, how can I distinguish true disease progression from a tumor‑flare reaction, and what are the appropriate management strategies for each scenario?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.